NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. Read more about NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
Biomarker use in colorectal cancer therapy. Read more about Biomarker use in colorectal cancer therapy.
Does use of the adjuvant! model influence use of adjuvant therapy through better risk communication? Read more about Does use of the adjuvant! model influence use of adjuvant therapy through better risk communication?
Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. Read more about Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer.
